Combined mucosal and systemic immunity following pulmonary delivery of ISCOMATRIX™ adjuvanted recombinant antigens
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvantImmunology & Cell Biology, 2009
- Single dose intranasal immunization with ISCOMATRIX™ vaccines to elicit antibody-mediated clearance of influenza virus requires delivery to the lower respiratory tractVaccine, 2009
- Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responsesVaccine, 2008
- Pulmonary delivery of ISCOMATRIX influenza vaccine induces both systemic and mucosal immunity with antigen dose sparingMucosal Immunology, 2008
- ISCOMATRIX™ adjuvant for prophylactic and therapeutic vaccinesExpert Review of Vaccines, 2007
- Inhalative vaccination with pneumococcal polysaccharide in healthy volunteersVaccine, 2005
- Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccineVaccine, 2005
- Mucosal immunisation and adjuvants: a brief overview of recent advances and challengesVaccine, 2003
- Characterization of a Panel of Insertion Mutants in Human Cytomegalovirus Glycoprotein BJournal of Virology, 2000
- Immunization Against InfluenzaJAMA, 1969